GlassScriptPhysician profile
Elizabeth A Groninger
NPI 1710991849
$2,131.14
in general payments reported to CMS, 2019-2025
18 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $224 · 2021: $284 · 2022: $237 · 2023: $339 · 2024: $361 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $972 · Entertainment: $16.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $971.63 |
| Entertainment | $16.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $841.98 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $354.33 | 2019-2025 | Dailies Total1, Precision7, Total30 |
| Coopervision INC. | $200.57 | 2019-2024 | Onefit Contact Lens, Clariti Contact Lens, Paragon Crt |
| Optos, INC. | $117.13 | 2019-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $96.87 | 2023-2025 | Xiidra, Miebo |
| Horizon Therapeutics Plc | $80.31 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $65.35 | 2024-2025 | Xdemvy |
| Rxsight INC | $55.56 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $45.79 | 2021-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.18 | 2019-2020 | |
| Abbvie INC. | $41.56 | 2022-2023 | |
| Sight Sciences, INC. | $41.30 | 2021 | |
| Sun Pharmaceutical Industries INC. | $39.96 | 2024 | |
| Abb Con-Cise Optical Group LLC | $30.84 | 2020-2022 | |
| Alcon Research LLC | $20.74 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $20.71 | 2022 | |
| Shire North American Group INC | $20.45 | 2019 | |
| Allergan, INC. | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Groninger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.